博雅生物：做好产品市场供应，保持合理存货水平

Group 1 - The company, Boya Bio-Pharmaceutical, is characterized as a blood product enterprise with high cash payment requirements and long production cycles [1] - The company plans to strictly regulate its product production schedule based on its raw plasma scale to ensure market supply and maintain reasonable inventory levels [1]